share_log

Jefferies Downgrades Deciphera Pharmaceuticals to Hold, Lowers Price Target to $25.6

Benzinga ·  Apr 29 11:15

Jefferies analyst Eun Yang downgrades Deciphera Pharmaceuticals (NASDAQ:DCPH) from Buy to Hold and lowers the price target from $26 to $25.6.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment